It’s not as if domestic manufacturing has suddenly become sloppy. A closer look will reveal the strides made by Indian pharma firms as they attempt to break into the complex drugs space, which attracts higher scrutiny.
This company accounts for more than 60% of carbon black exports from India and expected to be a key beneficiary of diversification of international supply chains
The stock has gained 82 percent in the last one year after languishing for much of the past decade
Prices of solar wafers have halved from the year ago period
It is a company with a healthy balance sheet, R&D-focused parentage and has a huge growth opportunity in the exports market
While tough agrochemical market is weighing on UPL’s revenue outlook, PI Industries is seeing traction in custom synthesis business
Lack of progress on improving the employee pyramid mix can weigh on profitability expansion of IT services companies
The API subsidiary Glenmark Life Sciences (GLS) is trading at undemanding valuations and is yet to reach its full potential
While drug sales continue to grow at a healthy pace the market is seeing higher competition from trade generics
Market coupling has been in discussion for some time now and analysts have been warning about the risk it poses to IEX
The company plans to focus on India and quality orders, customers
Total production cuts by the oil producing countries’ cartel is projected to reach 4.6 percent of the global demand in July
A credible profitability roadmap for pharmacy is the ask
Aditya Birla Fashion, Page Industries, TCNS Clothing reported weak results as demand worsened. Recovery hopes pushed to festival season
The company has a solid and differentiated business model, with promising growth potential
Modules manufactured in India are 37 percent more expensive than in China
Thanks to the boom in travel, the earnings trajectory should remain strong and investors could expect stock returns to closely mimic earnings
The company plans to build business in a cluster and exit underperforming hospitals
The stock is up 91 percent in the last one year and trades at premium valuations
Utilisation levels rose across the airlines in April
The company, with superior execution and solid business model, is on track to achieve its long-term strategic objectives
Aggressive expansion plan supports growth momentum
Vodafone Idea is behind in network investments and is ceding market share to competition
Emerging business segments hold good potential and are likely to be value accretive
Near-term positive outlook and attractive valuations create room for a stock upside